Leda Castilho
Universidade Federal do Rio de Janeiro
H-index: 36
Latin America-Brazil
Top articles of Leda Castilho
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month … | Scientific Reports | Metalia Puspitasari Prenali D Sattwika Dzerlina S Rahari Wynne Wijaya Auliana RP Hidayat | 2023/7/18 |
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection | Scientific Reports | Camila A Corsini Priscilla S Filgueiras Nathalie BF Almeida Daniel AP de Miranda Sarah VC Gomes | 2023/10/30 |
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 … | Plos one | Shayane Martins Rodrigues Gomes Andréia Carolinne de Souza Brito Wânia Ferraz Pereira Manfro Marcelo Ribeiro-Alves Roberto Stefan de Almeida Ribeiro | 2023/4/5 |
Conformational stability of SARS-CoV-2 glycoprotein spike variants | Iscience | Hiam RS Arruda Tulio M Lima Renata GF Alvim Fernanda BA Victorio Daniel PB Abreu | 2023/1/20 |
Espectrometria de massas: uma ferramenta versátil para a caracterização de anticorpos monoclonais terapêuticos | Cuadernos de Educación y Desarrollo | Sanclayver Corrêa Araújo Leda dos Reis Castilho Renato Sampaio Carvalho | 2023/12/14 |
Anti-SARS-CoV-2 IgG ELISA: Replacing the Absorbance Plate Reader by a Regular Scanner with Open-Source Software | Processes | Felipo D Rojas Soares Caio FC Marcellos Júlia NP Nogueira Daniel PB de Abreu Leda R Castilho | 2023/1/7 |
Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection | Vaccines | Momtchilo Russo Maria Cássia Mendes-Corrêa Bruna B Lins Victor Kersten Paulo CA Pernambuco Filho | 2023/11/20 |
From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics | Biochemical Engineering Journal | Renata GF Alvim Tulio M Lima Danielle AS Rodrigues Federico F Marsili Vicente BT Bozza | 2022/8/1 |
Multimodal chromatography combining steric exclusion and cation exchange as an intermediate downstream step to purify yellow fever virus-like particles | Túlio M Lima Ricardo A Medronho Leda R Castilho | 2022 | |
Immunogenicity, effectiveness, and safety of inactivated virus (CoronaVac) vaccine in a two-dose primary protocol and BNT162b2 heterologous booster in Brazil (Immunita-001): a … | Frontiers in immunology | Rafaella FQ Grenfell Nathalie BF Almeida Priscilla S Filgueiras Camila A Corsini Sarah VC Gomes | 2022/6/9 |
A Bioreactor System | 2022/4/28 | ||
Uncovering the structural flexibility of SARS-CoV-2 glycoprotein spike variants | bioRxiv | Hiam RS Arruda Tulio M Lima Renata GF Alvim Fernanda BA Victorio Daniel PB Abreu | 2022/4/20 |
Towards updatable, multivalent Covid vaccines: A platform process to produce trimeric spike protein of SARS-COV-2 variants expressed in HEK293 stable cell clones | Renata GF Alvim Tulio M Lima Federico F Marsili Leda R Castilho | 2022 | |
Virus-like particles (VLPs) as important tools for Flavivirus vaccine development | Leda R Castilho Nathalia R Mattos Wallace S Abreu Melissa LE Gutarra | 2022/10/31 | |
Functional profiling of antibody immune repertoires in convalescent zika virus disease patients | Frontiers in Immunology | Ahmed S Fahad Morgan R Timm Bharat Madan Katherine E Burgomaster Kimberly A Dowd | 2021/2/24 |
Effect of convalescent plasma in critically ill patients with COVID-19: an observational study | Frontiers in Medicine | Pedro Kurtz Cassia Righy Monica Gadelha Fernando A Bozza Patricia T Bozza | 2021/1/28 |
Polyclonal F (ab’) 2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency | Iscience | Luis Eduardo R Cunha Adilson A Stolet Marcelo A Strauch Victor AR Pereira Carlos H Dumard | 2021/11/19 |
Zika virus vaccines | 2021/1/26 | ||
Process intensification for the production of yellow fever virus‐like particles as potential recombinant vaccine antigen | Biotechnology and Bioengineering | Renata GF Alvim Túlio M Lima Jerson L Silva Guilherme AP de Oliveira Leda R Castilho | 2021/9 |
The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self | Journal of Experimental Medicine | Cecilia B Cavazzoni Vicente BT Bozza Tostes CV Lucas Luciana Conde Bruno Maia | 2021/7/22 |
